HEALTHEQUITY (HQY) Company Report

HealthEquity reported strong Q3 fiscal year 2026 financial results, with revenue up 7% year-over-year and adjusted EBITDA increasing 20% to $141.8 million. Net income grew 806% to $51.7 million, though non-GAAP net income, which excludes a prior-year legal settlement, increased 26% to $87.7 million.
The company raised its fiscal year 2026 guidance, now projecting revenue between $1.302 billion and $1.312 billion and adjusted EBITDA between $555 million and $565 million.
Key metrics showed continued growth, with HSA assets up 15% year-over-year to over $34 billion and HSA invested assets growing 29% to $17.5 billion. Total accounts exceeded 17 million, including over 10 million HSAs.
Strategic initiatives include the launch of a new direct HSA enrollment platform for ACA bronze plan participants and continued investment in security and AI capabilities. The company also repurchased approximately $94 million of its shares during the quarter, with $259 million remaining on its authorization.

2 days ago

HealthEquity Reports Strong Q3 2026 Results and Raises Fiscal Year 2026 Guidance

HQY

Earnings

Guidance Update

Share Buyback

HealthEquity delivered strong Q3 2026 financial results, with revenue up 7% year-over-year, non-GAAP net income increasing 26% to $87.7 million, and Adjusted EBITDA growing 20% to $141.8 million.
The company experienced significant growth in key metrics, including a 15% increase in HSA assets to $34 billion and a 6% rise in HSAs to 10 million.
HealthEquity raised its fiscal year 2026 guidance, now expecting revenue between $1.302 billion and $1.312 billion and Adjusted EBITDA between $555 million and $565 million.
Strategic initiatives include the launch of a new direct HSA enrollment platform to capitalize on expanded HSA eligibility for ACA bronze plans and continued share repurchases, with approximately $259 million remaining on the authorization.

2 days ago

HealthEquity Reports Strong Q3 2026 Results and Raises Fiscal Year 2026 Guidance

HQY

Earnings

Guidance Update

Share Buyback

HealthEquity (HQY) reported strong Q3 fiscal year 2026 results, with revenue up 7% year-over-year, net income up 806% to $51.7 million, and adjusted EBITDA up 20% to $141.8 million.
Key operational metrics showed robust growth, with HSA assets increasing 15% year-over-year to over $34 billion and HSA invested assets growing 29% to $17.5 billion. Total accounts reached over 17 million, including more than 10 million HSAs.
The company raised its fiscal year 2026 guidance, now projecting revenue between $1.302 and $1.312 billion, non-GAAP net income between $341 and $348 million, and adjusted EBITDA between $555 and $565 million.
Strategic initiatives include the launch of a new direct HSA enrollment platform for ACA exchanges, expansion of the HealthEquity Marketplace, and continued investments in AI and fraud prevention.
HealthEquity repurchased approximately $94 million of its shares during the quarter, with $259 million remaining on its share purchase authorization.

2 days ago

HealthEquity Reports Strong Q3 2026 Financial Results and Updates Fiscal Year Guidance

HQY

Earnings

Guidance Update

Share Buyback

HealthEquity reported a 7% increase in revenue to $322.2 million for the third quarter ended October 31, 2025.
Non-GAAP net income per diluted share increased 29% to $1.01, and Adjusted EBITDA grew 20% to $141.8 million for the quarter.
Total HSA Assets grew 15% to $34.4 billion and HSAs increased 6% to 10.1 million as of October 31, 2025.
The company returned $93.7 million to shareholders through stock repurchases during the third quarter.
For the fiscal year ending January 31, 2026, management expects revenues of $1.302 billion to $1.312 billion and non-GAAP net income per diluted share of $3.87 to $3.95.

2 days ago

HealthEquity Reports Strong Q2 2026 Results and Expanded HSA Eligibility

HQY

Earnings

Guidance Update

Share Buyback

HealthEquity reported strong financial results for Q2 2026, with revenue increasing 9%, net income up 67%, and adjusted EBITDA growing 18% to a record $151.1 million. Gross margin reached a record 71%.
HSA assets grew 12% year over year to over $33 billion, and total accounts increased 5% to over 17 million. Invested assets also saw significant growth, up 23% to $16.1 billion.
A budget bill passed in July 2025 expanded HSA eligibility, allowing Direct Primary Care and low-cost telehealth, and making individual Bronze and Catastrophic plans on ACA exchanges eligible for HSAs starting January 1, 2026. This change could provide access to 3-4 million more American families.
The company raised its outlook for fiscal year 2026 and significantly reduced direct fraud service costs from $3 million in Q1 to an exit run rate near one basis point of total HSA assets per year in Q2. HealthEquity also repurchased approximately $66 million of its outstanding shares during the quarter.

Sep 2, 2025, 11:28 PM

Earnings Transcripts

Quarterly earnings call transcripts for HEALTHEQUITY.

Get instant answers from SEC filings, earnings calls & more

Get instant analysis when filings drop